CFDE Data Portal | Search PTMAP5

	Label	Description
	PTMAP5 associations Collection (Entity type)	Associations for PTMAP5_associations
	PTMAP5 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PTMAP5 Gene (Entity type)	ENSG00000293057 - prothymosin alpha pseudogene 5
	GSE73573 KDM1B knockdown 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE139178 GDC-0068 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978 GSE180930 cisplatin 6 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239688 canagliflozin 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE98856 adenosine 6 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

PTMAP5 associations

Associations for PTMAP5_associations

PTMAP5 associations.tsv

A file from IDG as part of the Harmonizome project

PTMAP5

ENSG00000293057 - prothymosin alpha pseudogene 5

GSE73573 KDM1B knockdown 1 v 0 human dn

A Gene Set from LINCS

GSE139178 GDC-0068 3 v 1 human dn

A Gene Set from LINCS

GSE119978 GSE180930 cisplatin 6 v 1 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 8 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human dn

A Gene Set from LINCS

GSE239688 canagliflozin 2 v 1 human up

A Gene Set from LINCS

GSE98856 adenosine 6 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.